The hope is that with a much faster time from approval -> production, in theory we could reassess in October / December / February and vaccinate against the most virulent strains that are actually showing up in populations. There are reports that Moderna had a vaccine developed in two days once they received the sequence from researchers. If they or similar companies received "platform" approval to ship new vaccines with abbreviated testing, it could dramatically change how we vaccinate for the flu.